Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

ADC Therapeutics SA

ADCT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ADCT by members of U.S. Congress

ADCT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ADCT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ADCT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ADCT holdings by institutional investors

Quarterly net insider trading by ADCT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ADCT

Quiver Logo

No former government officials on record as having lobbied for ADCT

Revolving Door Dashboard

ADCT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ADCT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ADCT Income Statement
ADCT Balance Sheet
ADCT Cash Flow
U.S. Patents

New ADCT patent grants

  • Patent Title: Anti-il13rα2 antibodies May. 07, 2024
  • Patent Title: Combination therapy with an anti-cd25 antibody-drug conjugate Mar. 07, 2023
  • Patent Title: Dosage regimes for the administration of an anti-cd25 adc Aug. 30, 2022
  • Patent Title: Pyrrolobenzodiazepine-antibody conjugates Jul. 12, 2022
  • Patent Title: Dosage regimes for the administration of an anti-cd19 adc May. 03, 2022
  • Patent Title: Pyrrolobenzodiazepine-antibody conjugates Nov. 02, 2021
  • Patent Title: Method for treating breast cancer Aug. 10, 2021
  • Patent Title: Pyrrolobenzodiazepine-antibody conjugates Oct. 13, 2020
  • Patent Title: Pyrrolobenzodiazepine-antibody conjugates Sep. 22, 2020
  • Patent Title: Pyrrolobenzodiazepine-anti-cd22 antibody conjugates Jul. 28, 2020
  • Patent Title: Combination therapy with an anti-axl antibody-drug conjugate Jan. 28, 2020
  • Patent Title: Pyrrolobenzodiazepine-anti-cd22 antibody conjugates Mar. 20, 2018
  • Patent Title: Anti-kidney associated antigen 1 (kaag1) antibodies Jan. 02, 2018
  • Patent Title: Antibodies against kidney associated antigen 1 and antigen binding fragments thereof Nov. 28, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ADCT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ADCT News

Recent insights relating to ADCT

CNBC Recommendations

Recent picks made for ADCT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ADCT

ADCT Analyst Ratings

ADCT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ADCT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ADCT stock a Buy, Sell, or Hold?

  • What is the price target for $ADCT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ADCT Top Shareholders
Shareholder
Shares Held
ADCT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ADCT stock?

  • Who owns the most shares of $ADCT stock?

  • What funds own $ADCT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ADCT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ADCT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ADCT

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

  • Address Epalinges, V8
  • Market Cap 164.7 million
  • Employees 193
  • Industrial Classification Pharmaceutical Preparations

ADC Therapeutics SA (ADCT) Historical Stock Prices

ADC Therapeutics SA (ADCT) closed at $1.29 on September 24, 2026. Over the past year its adjusted close ranged from $0.9601 to $4.88. Daily prices go back to May 15, 2020, 1,598 trading days in all.

  • 1 month+24.04%
  • 3 months+24.04%
  • Year to date-63.46%
  • 1 year-63.76%
  • 3 years+59.55%
  • 5 years-95.44%
  • Max-95.65%
See every congressional and insider trade on the ADCT price chart

Quiver Premium charts ADCT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 1.30 1.31 1.24 1.29 1.29 1,575,647
Sep 23, 2026 1.24 1.32 1.21 1.31 1.31 1,972,380
Sep 22, 2026 1.13 1.25 1.12 1.23 1.23 1,674,295
Sep 21, 2026 1.05 1.13 1.03 1.12 1.12 1,899,275
Sep 18, 2026 1.06 1.15 1.05 1.05 1.05 1,580,274
Sep 17, 2026 1.06 1.10 1.01 1.06 1.06 1,545,569
Sep 16, 2026 1.09 1.09 1.02 1.05 1.05 3,316,970
Sep 15, 2026 1.12 1.12 1.03 1.09 1.09 1,259,823
Sep 14, 2026 1.07 1.12 1.06 1.11 1.11 808,479
Sep 11, 2026 1.13 1.16 1.04 1.07 1.07 989,105
Sep 10, 2026 1.21 1.24 1.07 1.11 1.11 957,194
Sep 9, 2026 1.28 1.31 1.19 1.22 1.22 1,709,284
Sep 8, 2026 1.33 1.35 1.27 1.30 1.30 930,761
Sep 4, 2026 1.30 1.37 1.30 1.36 1.36 1,478,303
Sep 3, 2026 1.32 1.37 1.30 1.32 1.32 2,774,762
Sep 2, 2026 1.23 1.35 1.23 1.32 1.32 1,955,644
Sep 1, 2026 1.15 1.24 1.14 1.24 1.24 1,149,641
Aug 31, 2026 1.13 1.19 1.12 1.17 1.17 1,251,778
Aug 28, 2026 1.11 1.17 1.07 1.14 1.14 2,577,910
Aug 27, 2026 1.05 1.14 1.05 1.12 1.12 1,403,771
Aug 26, 2026 1.04 1.07 1.01 1.05 1.05 1,947,239
Aug 25, 2026 0.9755 1.05 0.9600 1.04 1.04 3,927,974
Aug 24, 2026 0.9900 1.00 0.9514 0.9651 0.9651 640,512
Aug 21, 2026 0.9740 1.00 0.9700 0.9966 0.9966 1,088,237
Aug 20, 2026 1.02 1.04 0.9497 0.9601 0.9601 2,422,878
Aug 19, 2026 1.05 1.09 1.01 1.04 1.04 1,900,697
Aug 18, 2026 1.05 1.08 1.03 1.03 1.03 3,444,158
Aug 17, 2026 0.9900 1.10 0.9500 1.10 1.10 3,732,948
Aug 14, 2026 1.02 1.04 1.00 1.01 1.01 1,347,088
Aug 13, 2026 1.07 1.10 0.9393 1.05 1.05 2,190,300
Aug 12, 2026 1.20 1.23 1.16 1.23 1.23 563,556
Aug 11, 2026 1.11 1.20 1.11 1.18 1.18 664,343
Aug 10, 2026 1.14 1.17 1.12 1.13 1.13 569,554
Aug 7, 2026 1.08 1.17 1.08 1.13 1.13 534,556
Aug 6, 2026 1.07 1.13 1.07 1.13 1.13 722,735
Aug 5, 2026 1.11 1.15 1.07 1.07 1.07 971,135
Aug 4, 2026 1.05 1.12 1.04 1.10 1.10 1,368,010
Aug 3, 2026 1.07 1.08 1.03 1.05 1.05 866,391
Jul 31, 2026 1.11 1.12 1.04 1.05 1.05 757,729
Jul 30, 2026 1.09 1.13 1.07 1.11 1.11 887,735
Jul 29, 2026 1.10 1.12 1.07 1.10 1.10 924,496
Jul 28, 2026 1.14 1.15 1.10 1.11 1.11 747,766
Jul 27, 2026 1.18 1.21 1.12 1.14 1.14 787,746
Jul 24, 2026 1.25 1.26 1.15 1.15 1.15 725,745
Jul 23, 2026 1.20 1.24 1.20 1.22 1.22 579,880
Jul 22, 2026 1.24 1.28 1.21 1.24 1.24 787,166
Jul 21, 2026 1.24 1.30 1.24 1.27 1.27 861,184
Jul 20, 2026 1.33 1.40 1.26 1.26 1.26 659,546
Jul 17, 2026 1.32 1.46 1.31 1.35 1.35 1,331,582
Jul 16, 2026 1.27 1.35 1.23 1.35 1.35 957,727
Jul 15, 2026 1.22 1.29 1.21 1.28 1.28 549,729
Jul 14, 2026 1.22 1.25 1.21 1.23 1.23 699,106
Jul 13, 2026 1.25 1.28 1.23 1.25 1.25 635,107
Jul 10, 2026 1.32 1.32 1.21 1.29 1.29 1,326,400
Jul 9, 2026 1.29 1.33 1.24 1.30 1.30 548,031
Jul 8, 2026 1.33 1.37 1.27 1.28 1.28 2,426,259
Jul 7, 2026 1.24 1.44 1.23 1.35 1.35 3,125,441
Jul 6, 2026 1.20 1.25 1.15 1.25 1.25 934,234
Jul 2, 2026 1.14 1.23 1.13 1.19 1.19 1,804,530
Jul 1, 2026 1.05 1.18 1.04 1.14 1.14 1,749,529
Jun 30, 2026 1.06 1.12 1.01 1.07 1.07 890,283
Jun 29, 2026 1.05 1.07 1.00 1.03 1.03 1,039,823
Jun 26, 2026 1.02 1.06 1.00 1.02 1.02 4,447,685
Jun 25, 2026 1.07 1.10 1.00 1.04 1.04 1,730,608
Jun 24, 2026 1.13 1.16 1.06 1.07 1.07 2,259,007
Jun 23, 2026 1.08 1.17 1.06 1.15 1.15 1,132,709
Jun 22, 2026 1.10 1.14 1.04 1.09 1.09 1,049,831
Jun 18, 2026 1.09 1.12 1.05 1.09 1.09 1,725,034
Jun 17, 2026 1.02 1.13 1.01 1.11 1.11 2,078,345
Jun 16, 2026 1.07 1.09 0.9811 0.9963 0.9963 1,284,089
Jun 15, 2026 1.08 1.10 1.02 1.05 1.05 1,851,125
Jun 12, 2026 1.06 1.12 1.02 1.05 1.05 1,552,071
Jun 11, 2026 1.10 1.14 1.06 1.06 1.06 1,614,428
Jun 10, 2026 1.09 1.22 1.07 1.10 1.10 3,106,586
Jun 9, 2026 0.9700 1.16 0.9700 1.10 1.10 8,628,894
Jun 8, 2026 1.07 1.07 0.7796 0.9777 0.9777 12,492,750
Jun 5, 2026 1.36 1.38 1.01 1.03 1.03 7,646,246
Jun 4, 2026 1.37 1.57 1.31 1.32 1.32 12,639,784
Jun 3, 2026 3.18 3.18 3.02 3.08 3.08 1,648,295
Jun 2, 2026 3.36 3.37 3.16 3.17 3.17 796,769
Jun 1, 2026 3.48 3.49 3.35 3.40 3.40 620,444
May 29, 2026 3.46 3.49 3.37 3.40 3.40 689,879
May 28, 2026 3.43 3.46 3.38 3.45 3.45 454,767
May 27, 2026 3.56 3.71 3.42 3.43 3.43 602,781
May 26, 2026 3.42 3.53 3.38 3.51 3.51 793,909
May 22, 2026 3.41 3.45 3.35 3.39 3.39 648,500
May 21, 2026 3.22 3.45 3.20 3.40 3.40 862,217
May 20, 2026 3.16 3.27 3.16 3.24 3.24 664,922
May 19, 2026 3.13 3.23 3.10 3.14 3.14 885,284
May 18, 2026 3.26 3.34 3.13 3.17 3.17 1,434,553
May 15, 2026 3.33 3.39 3.19 3.25 3.25 1,103,265
May 14, 2026 3.49 3.53 3.36 3.36 3.36 903,984
May 13, 2026 3.40 3.49 3.39 3.48 3.48 1,048,156
May 12, 2026 3.48 3.54 3.37 3.43 3.43 1,201,444
May 11, 2026 3.50 3.71 3.46 3.48 3.48 1,100,240
May 8, 2026 3.74 3.77 3.50 3.50 3.50 1,632,490
May 7, 2026 3.87 3.87 3.71 3.75 3.75 1,408,378
May 6, 2026 3.83 4.13 3.82 3.86 3.86 2,630,420
May 5, 2026 3.73 3.87 3.60 3.76 3.76 2,158,277
May 4, 2026 3.58 3.88 3.36 3.68 3.68 1,842,474
May 1, 2026 3.78 3.85 3.72 3.83 3.83 979,903
Apr 30, 2026 3.79 3.85 3.72 3.78 3.78 821,952
Apr 29, 2026 3.76 3.83 3.67 3.78 3.78 946,804
Apr 28, 2026 3.75 3.83 3.72 3.77 3.77 701,403
Apr 27, 2026 3.88 4.09 3.76 3.76 3.76 770,839
Apr 24, 2026 3.95 4.00 3.87 3.94 3.94 933,915
Apr 23, 2026 4.07 4.10 3.96 3.96 3.96 640,291
Apr 22, 2026 4.09 4.17 4.03 4.09 4.09 651,503
Apr 21, 2026 4.25 4.32 4.04 4.11 4.11 1,382,102
Apr 20, 2026 4.26 4.33 4.21 4.25 4.25 844,362
Apr 17, 2026 4.44 4.50 4.28 4.28 4.28 544,604
Apr 16, 2026 4.38 4.82 4.24 4.38 4.38 2,206,370
Apr 15, 2026 3.85 4.38 3.80 4.37 4.37 2,733,498
Apr 14, 2026 3.85 3.99 3.83 3.86 3.86 542,053
Apr 13, 2026 3.73 3.92 3.73 3.81 3.81 538,009
Apr 10, 2026 3.79 3.82 3.69 3.74 3.74 644,144
Apr 9, 2026 3.69 3.81 3.69 3.76 3.76 630,057
Apr 8, 2026 3.94 3.94 3.69 3.73 3.73 541,620
Apr 7, 2026 3.65 3.78 3.46 3.72 3.72 800,567
Apr 6, 2026 3.76 3.83 3.66 3.67 3.67 629,822
Apr 2, 2026 3.70 3.97 3.60 3.78 3.78 1,355,063
Apr 1, 2026 3.81 3.83 3.70 3.80 3.80 744,757
Mar 31, 2026 3.73 3.81 3.63 3.75 3.75 919,138
Mar 30, 2026 3.69 3.78 3.56 3.64 3.64 678,681
Mar 27, 2026 3.89 4.00 3.60 3.70 3.70 1,005,368
Mar 26, 2026 3.89 4.05 3.89 3.96 3.96 485,905
Mar 25, 2026 3.99 4.11 3.94 3.97 3.97 523,473
Mar 24, 2026 3.97 4.00 3.87 3.94 3.94 406,143
Mar 23, 2026 4.10 4.12 3.94 4.05 4.05 662,767
Mar 20, 2026 4.12 4.12 3.84 3.86 3.86 2,421,483
Mar 19, 2026 3.94 4.09 3.92 4.04 4.04 429,805
Mar 18, 2026 4.13 4.13 3.95 4.01 4.01 642,215
Mar 17, 2026 4.24 4.24 4.08 4.11 4.11 526,418
Mar 16, 2026 4.17 4.30 4.15 4.22 4.22 686,141
Mar 13, 2026 4.36 4.56 4.12 4.13 4.13 815,860
Mar 12, 2026 4.81 4.81 4.24 4.35 4.35 939,695
Mar 11, 2026 4.74 4.98 4.63 4.88 4.88 1,271,179
Mar 10, 2026 4.54 4.95 4.20 4.80 4.80 1,564,695
Mar 9, 2026 4.03 4.23 4.03 4.23 4.23 703,623
Mar 6, 2026 4.07 4.34 4.05 4.11 4.11 541,384
Mar 5, 2026 4.22 4.22 4.03 4.19 4.19 1,516,795
Mar 4, 2026 4.11 4.41 4.05 4.24 4.24 2,103,550
Mar 3, 2026 4.05 4.17 4.00 4.05 4.05 942,957
Mar 2, 2026 4.02 4.22 3.94 4.18 4.18 521,598
Feb 27, 2026 4.04 4.18 3.94 4.10 4.10 553,910
Feb 26, 2026 4.26 4.26 4.02 4.13 4.13 576,985
Feb 25, 2026 4.41 4.44 4.24 4.27 4.27 627,625
Feb 24, 2026 4.42 4.68 4.36 4.39 4.39 755,009
Feb 23, 2026 4.11 4.41 4.11 4.41 4.41 1,157,167
Feb 20, 2026 4.18 4.24 4.10 4.10 4.10 648,165
Feb 19, 2026 4.06 4.25 4.00 4.22 4.22 1,607,493
Feb 18, 2026 4.14 4.25 4.06 4.13 4.13 780,914
Feb 17, 2026 3.97 4.20 3.85 4.18 4.18 1,581,443
Feb 13, 2026 4.03 4.23 3.98 3.99 3.99 642,648
Feb 12, 2026 3.92 4.02 3.85 4.02 4.02 463,619
Feb 11, 2026 3.94 3.97 3.66 3.92 3.92 463,894
Feb 10, 2026 4.01 4.10 3.89 3.90 3.90 380,165
Feb 9, 2026 4.01 4.07 3.88 3.99 3.99 542,173
Feb 6, 2026 3.97 4.20 3.93 4.01 4.01 1,047,410
Feb 5, 2026 4.03 4.19 3.88 3.91 3.91 741,226
Feb 4, 2026 3.91 4.18 3.79 4.09 4.09 858,086
Feb 3, 2026 3.93 3.99 3.77 3.90 3.90 531,847
Feb 2, 2026 3.58 4.02 3.58 3.90 3.90 713,379
Jan 30, 2026 3.73 3.75 3.54 3.61 3.61 754,484
Jan 29, 2026 3.54 3.81 3.50 3.76 3.76 746,290
Jan 28, 2026 3.60 3.62 3.25 3.54 3.54 1,389,567
Jan 27, 2026 3.62 3.64 3.52 3.59 3.59 659,505
Jan 26, 2026 3.61 3.63 3.51 3.62 3.62 613,056
Jan 23, 2026 3.76 3.84 3.57 3.61 3.61 758,387
Jan 22, 2026 3.62 3.87 3.58 3.80 3.80 501,486
Jan 21, 2026 3.51 3.62 3.48 3.57 3.57 1,087,910
Jan 20, 2026 3.53 3.62 3.49 3.52 3.52 357,791
Jan 16, 2026 3.50 3.62 3.44 3.62 3.62 754,248
Jan 15, 2026 3.77 3.84 3.50 3.55 3.55 491,164
Jan 14, 2026 3.70 3.79 3.65 3.71 3.71 553,592
Jan 13, 2026 3.84 3.85 3.69 3.70 3.70 504,300
Jan 12, 2026 3.67 3.89 3.58 3.82 3.82 897,980
Jan 9, 2026 3.62 3.83 3.54 3.66 3.66 637,664
Jan 8, 2026 3.62 3.66 3.52 3.57 3.57 382,800
Jan 7, 2026 3.56 3.75 3.50 3.65 3.65 819,067
Jan 6, 2026 3.49 3.58 3.49 3.54 3.54 818,759
Jan 5, 2026 3.65 3.65 3.38 3.56 3.56 645,280
Jan 2, 2026 3.56 3.60 3.47 3.52 3.52 1,411,444
Dec 31, 2025 3.53 3.64 3.53 3.53 3.53 555,938
Dec 30, 2025 3.50 3.57 3.48 3.50 3.50 389,162
Dec 29, 2025 3.47 3.56 3.46 3.50 3.50 562,124
Dec 26, 2025 3.54 3.54 3.46 3.51 3.51 549,148
Dec 24, 2025 3.50 3.65 3.50 3.53 3.53 392,465
Dec 23, 2025 3.71 3.71 3.35 3.50 3.50 1,358,884
Dec 22, 2025 3.74 3.89 3.68 3.70 3.70 544,203
Dec 19, 2025 4.00 4.05 3.72 3.73 3.73 3,187,089
Dec 18, 2025 3.70 3.92 3.56 3.90 3.90 1,997,364
Dec 17, 2025 3.97 3.98 3.67 3.67 3.67 735,352
Dec 16, 2025 4.15 4.28 3.88 3.97 3.97 1,859,670
Dec 15, 2025 4.23 4.26 4.06 4.21 4.21 2,502,728
Dec 12, 2025 4.18 4.32 4.09 4.23 4.23 1,665,928
Dec 11, 2025 4.00 4.19 3.99 4.18 4.18 1,112,596
Dec 10, 2025 3.46 4.04 3.31 4.01 4.01 2,510,777
Dec 9, 2025 3.22 3.54 3.15 3.53 3.53 1,537,854
Dec 8, 2025 3.33 3.41 3.21 3.22 3.22 1,899,113
Dec 5, 2025 3.52 3.60 3.25 3.29 3.29 1,844,282
Dec 4, 2025 3.72 3.90 3.49 3.54 3.54 2,433,298
Dec 3, 2025 4.44 4.55 2.94 3.95 3.95 11,545,507
Dec 2, 2025 4.30 4.62 4.23 4.60 4.60 1,309,400
Dec 1, 2025 4.23 4.26 4.16 4.24 4.24 563,274
Nov 28, 2025 4.39 4.42 4.26 4.30 4.30 254,910
Nov 26, 2025 4.37 4.45 4.29 4.33 4.33 388,157
Nov 25, 2025 4.39 4.44 4.21 4.39 4.39 525,181
Nov 24, 2025 4.10 4.42 4.04 4.37 4.37 971,593
Nov 21, 2025 3.96 4.13 3.95 4.02 4.02 1,532,798
Nov 20, 2025 4.12 4.29 3.97 3.99 3.99 640,116
Nov 19, 2025 3.99 4.15 3.92 4.02 4.02 636,872
Nov 18, 2025 3.95 4.10 3.91 4.00 4.00 718,212
Nov 17, 2025 3.95 4.15 3.91 3.97 3.97 599,137
Nov 14, 2025 3.94 4.14 3.91 3.96 3.96 591,989
Nov 13, 2025 4.00 4.19 3.90 4.05 4.05 788,397
Nov 12, 2025 3.97 4.09 3.89 4.05 4.05 854,045
Nov 11, 2025 4.17 4.25 3.87 3.97 3.97 587,757
Nov 10, 2025 4.03 4.36 3.93 4.21 4.21 681,089
Nov 7, 2025 4.09 4.14 3.63 4.04 4.04 954,072
Nov 6, 2025 3.98 4.22 3.96 4.16 4.16 956,072
Nov 5, 2025 4.03 4.08 3.88 4.00 4.00 1,272,492
Nov 4, 2025 4.05 4.18 4.02 4.03 4.03 466,830
Nov 3, 2025 4.41 4.43 4.07 4.18 4.18 920,393
Oct 31, 2025 4.61 4.67 4.35 4.46 4.46 533,797
Oct 30, 2025 4.61 4.80 4.52 4.63 4.63 573,244
Oct 29, 2025 4.49 4.72 4.41 4.61 4.61 1,121,359
Oct 28, 2025 4.29 4.53 4.21 4.43 4.43 549,140
Oct 27, 2025 4.20 4.32 4.17 4.29 4.29 509,941
Oct 24, 2025 4.15 4.19 4.05 4.09 4.09 492,025
Oct 23, 2025 4.06 4.11 3.98 4.07 4.07 420,971
Oct 22, 2025 4.13 4.17 3.92 4.07 4.07 774,198
Oct 21, 2025 4.28 4.31 4.11 4.13 4.13 709,667
Oct 20, 2025 4.15 4.30 4.11 4.29 4.29 1,161,670
Oct 17, 2025 4.20 4.20 4.02 4.08 4.08 737,660
Oct 16, 2025 4.19 4.34 4.09 4.13 4.13 1,080,217
Oct 15, 2025 4.14 4.37 4.10 4.26 4.26 1,046,389
Oct 14, 2025 4.50 4.62 4.08 4.11 4.11 1,944,652
Oct 13, 2025 4.45 4.64 4.28 4.61 4.61 962,752
Oct 10, 2025 4.58 4.58 4.30 4.42 4.42 694,303
Oct 9, 2025 4.54 4.74 4.45 4.59 4.59 1,303,686
Oct 8, 2025 4.35 4.62 4.30 4.54 4.54 1,203,026
Oct 7, 2025 4.43 4.48 4.15 4.31 4.31 1,258,636
Oct 6, 2025 4.23 4.67 4.19 4.43 4.43 2,610,282
Oct 3, 2025 4.00 4.31 3.99 4.08 4.08 1,396,679
Oct 2, 2025 4.03 4.11 3.95 3.98 3.98 784,654
Oct 1, 2025 3.94 4.07 3.94 4.00 4.00 1,181,628
Sep 30, 2025 3.96 4.07 3.88 4.00 4.00 1,601,462
Sep 29, 2025 3.66 4.06 3.62 4.02 4.02 1,328,149
Sep 26, 2025 3.47 3.67 3.44 3.65 3.65 1,257,389
Sep 25, 2025 3.50 3.52 3.37 3.45 3.45 869,298
Sep 24, 2025 3.41 3.66 3.40 3.56 3.56 981,262

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
ADC Therapeutics SA Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ADCT, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation